The Role of Mast Cells in Stroke.
Edoardo ParrellaVanessa PorriniMarina BenareseMarina PizziPublished in: Cells (2019)
Mast cells (MCs) are densely granulated perivascular resident cells of hematopoietic origin. Through the release of preformed mediators stored in their granules and newly synthesized molecules, they are able to initiate, modulate, and prolong the immune response upon activation. Their presence in the central nervous system (CNS) has been documented for more than a century. Over the years, MCs have been associated with various neuroinflammatory conditions of CNS, including stroke. They can exacerbate CNS damage in models of ischemic and hemorrhagic stroke by amplifying the inflammatory responses and promoting brain-blood barrier disruption, brain edema, extravasation, and hemorrhage. Here, we review the role of these peculiar cells in the pathophysiology of stroke, in both immature and adult brain. Further, we discuss the role of MCs as potential targets for the treatment of stroke and the compounds potentially active as MCs modulators.
Keyphrases
- atrial fibrillation
- cerebral ischemia
- blood brain barrier
- induced apoptosis
- immune response
- white matter
- resting state
- cell cycle arrest
- oxidative stress
- subarachnoid hemorrhage
- small molecule
- bone marrow
- dendritic cells
- multiple sclerosis
- toll like receptor
- endoplasmic reticulum stress
- young adults
- risk assessment
- inflammatory response
- quality improvement
- smoking cessation
- replacement therapy